“autoimmune” Archives

Entry Author Date Location
Santarus Adds Two Drugs 09/13/10 San Diego
Nuon Adds $10M Debt, Options 08/12/10 San Francisco
Allozyne, After a Stealthy Year on a Slim Budget, Re-Emerges with MS Drug and Fat Pipeline 07/14/10 Seattle
Tolera Therapeutics, Cleveland Clinic Spinoff Focused on Immune Disorders, Raises $4M 06/04/10 Detroit Ann Arbor
Alder, Bristol Arthritis Drug Shows “Outstanding” Results in Trial, Lead Researcher Says 05/17/10 Seattle
Alder Seeks to Treat Cancer in a Radical Way, Fighting Inflammation, Not Tumors 05/13/10 Seattle
Taligen Adds Maraganore to Board 04/15/10 Boston
Kineta Nabs $600K NIH Grant 04/05/10 Seattle
Adaptive TCR, a Fred Hutch Spinoff, Nabs $4.5M to Uncover Immune System Secrets 03/26/10 Seattle
Innovation Northwest Wrapup: Alder, Tekmira, Acucela, & Other Emerging Little Biotechs 03/19/10 Seattle
Ligand Drug OK’d in Europe 03/12/10 San Diego
Tolerx, After a Decade and $150M, Eagerly Awaits Data from Big Diabetes Trial 03/04/10 Boston
NanoString Chairman Bill Young Scopes Out Diagnostic Future, Considers Bay Area Expansion 02/19/10 Seattle
Eleven Biotherapeutics Raises $35M, Seeks to Crank the Amplifer Up on Protein Drugs 02/17/10 Boston
VentiRx Nabs $25M, Gilead Deepens Seattle Roots, Sage Strikes Deal With Pfizer & More Seattle-Area Life Sciences News 01/14/10 Seattle
Lycera, a Midwestern Biotech Star, Moves Head Office to Boston, Hires Biogen Vet as CEO 01/07/10 Boston
VLST Cuts Jobs To Preserve Cash, Still Feeding Novo Nordisk Pipeline 12/22/09 Seattle
Biogen Idec’s Dream: Antibodies That Kill Two Birds With One Stone 12/09/09 Boston
ZymoGenetics Sells Inflammatory Drug to Old Parent, Novo Nordisk, for $24M Upfront 12/08/09 Seattle
Kineta Cuts Deal With MPI 10/27/09 Seattle
Biotech Pioneer Steve Gillis on Life as a VC, How Today’s Entrepreneurs Can Make It, and Seattle’s Future in Life Sciences (Part 1) 09/23/09 Seattle
Novo Nordisk’s Historic Mistake is Seattle’s Future Gain, Says Novo CEO 09/18/09 Seattle
Zymo Drug Fails Arthritis Trials 09/10/09 Seattle
Intellikine, Stocked With Cash, Pushes Portfolio of Drugs Against Biology’s Hot Targets 08/18/09 San Diego
Avila Therapeutics Gets $30M to Push Ahead With Covalent Drugs 07/27/09 Boston
ZymoGenetics Picks Up Mojo, Dendreon Looks Southeast, Cell Therapeutics Raises Dough & More Seattle-Area Life Sciences News 07/23/09 Seattle
ZymoGenetics Picks Up Some of Human Genome Sciences’ Mojo With Lupus Drug 07/21/09 Seattle
Targeted Genetics Dumps Lease, Amgen’s Dmab Works in Cancer Trial, Theraclone Nabs Cash, & More Seattle-Area Life Sciences News 07/09/09 Seattle
Kineta Acquires Multiple Sclerosis, Diabetes Drug Candidates to Test Unusual Biotech Strategy 07/08/09 Seattle
ASCO Weekend Recap: OncoGenex, Seattle Genetics, Vulcan-Backed BiPar Show Off Cancer Drug Results 06/01/09 Seattle
Page 2 of 3 « previous page · next page »